Empowering Equity in Cancer Clinical Research

Reducing Cancer Clinical Trial Disparities

Driving actionable change to eliminate disparities in clinical trials and ensure equitable health outcomes for all communities.

Services

All the Tools You Need for Inclusive Clinical Research

Feature these key service categories

Study Design

Scale trials from preclinical to Phase 4, expanding scope & access across oncology while integrating social determinants of health into design

Study Scalability

Scale oncology trials from preclinical to Phase 4, integrating social determinants of health to enhance access, equity, design, and real-world impact

Community Program Development

Design and implement cancer research initiatives, generate evidence-based strategies, and tailor recruitment for underserved communities.

Disease Surveillance

Leverage data systems to track cancer incidence in NYC and assess the impact of community initiatives on prevention, detection, and equity.

Community Program Assessment & Analysis

Identify disparities in cancer research by evaluating health programs, policies, and systems to assess effectiveness and inform equity-driven improvements.

Compliance and Regulatory

Audit preparation and readiness (Sponsor, Government, Institutional).

Operational Management

Evaluate pre-existing clinical trials to monitor operations, accruals and also study reviews.

Training

Clinical Research Operations, Disease Surveillance, Design, Scalability

Why Us

Why Partner with EQ Trial Network?

Expertise in Inclusive Research

Navigate the complex landscape of clinical research regulations while maintaining ethical standards.

Patient-Centered Strategies

Focused on building trust with underrepresented communities.

Data-Driven Approach

Leverage cutting-edge analytics to track and measure impact.

Proven Track Record

Documented success in transforming clinical trial outcomes.

A Disparity-Focused Approach to Transform Clinical Research

Our disparity-focused consulting solutions are built to identify gaps, design interventions, and measure impact to reduce inequities in cancer clinical trials.

About Our Approach

Founder

Vidhisha Mulani

“Innovation within clinical research means nothing if it does not reach the communities that need in the most especially in New York City”

Vidhisha Mulani

A cancer clinical research scientist
Leave us a message